PLAUR and breast carcinoma: The same consideration also applies to another study that similarly explored the theranostic targeting of uPAR in a metastatic breast cancer model using a 111In/177Lu-conjugated recombinant anti-uPAR antagonist antibody 2G10 IgG [166,167].